JP2024531409A5 - - Google Patents
Info
- Publication number
- JP2024531409A5 JP2024531409A5 JP2024510434A JP2024510434A JP2024531409A5 JP 2024531409 A5 JP2024531409 A5 JP 2024531409A5 JP 2024510434 A JP2024510434 A JP 2024510434A JP 2024510434 A JP2024510434 A JP 2024510434A JP 2024531409 A5 JP2024531409 A5 JP 2024531409A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- seq
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/113913 | 2021-08-20 | ||
| CN2021113913 | 2021-08-20 | ||
| PCT/CN2022/113739 WO2023020621A1 (en) | 2021-08-20 | 2022-08-19 | Anti-ccr8 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531409A JP2024531409A (ja) | 2024-08-29 |
| JP2024531409A5 true JP2024531409A5 (cg-RX-API-DMAC7.html) | 2025-08-26 |
Family
ID=85239303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510434A Pending JP2024531409A (ja) | 2021-08-20 | 2022-08-19 | 抗ccr8抗体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250019451A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4388009A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024531409A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240046533A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118176210A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022331786A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3225986A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310938A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024002238A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023020621A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI890283B (zh) | 2020-02-14 | 2025-07-11 | 美商基利科學股份有限公司 | 結合ccr8之抗體及融合蛋白及其用途 |
| AU2023319869A1 (en) * | 2022-08-04 | 2025-02-20 | Beone Medicines I Gmbh | Anti-ccr8 antibodies and methods of use |
| CA3265264A1 (en) | 2022-08-19 | 2024-02-22 | Fibrogen, Inc. | CCR8 ANTIBODIES AND THEIR USES |
| CN120303296A (zh) * | 2022-10-02 | 2025-07-11 | 瑞美德生物医药科技有限公司 | C-c趋化因子受体8型(ccr8)拮抗剂抗体 |
| WO2024248037A1 (ja) | 2023-05-30 | 2024-12-05 | 塩野義製薬株式会社 | Ccr8を抗原として認識する二重特異性抗体 |
| AU2024305430A1 (en) * | 2023-06-12 | 2026-01-22 | Nanjing Probio Biotech Co., Ltd. | Antibody binding to human ccr8 and the use thereof |
| KR20260070101A (ko) * | 2023-07-07 | 2026-05-18 | 치루 파머수티컬 컴퍼니 리미티드 | 항-인간 ccr8 단클론 항체의 약학적 제제 및 이의 용도 |
| TW202540200A (zh) | 2023-12-01 | 2025-10-16 | 美商基利科學股份有限公司 | 抗fap-light融合蛋白及其用途 |
| CN122459678A (zh) | 2023-12-29 | 2026-07-24 | 百时美施贵宝公司 | KRAS抑制剂与Treg耗竭剂的组合疗法 |
| WO2025259871A1 (en) | 2024-06-14 | 2025-12-18 | Gilead Sciences, Inc. | Anti-ccr8 antibodies and uses thereof |
| CN119371535B (zh) * | 2024-09-20 | 2025-07-11 | 百济神州(上海)生物科技有限公司 | 抗ccr8抗体及其用途 |
| CN119841954B (zh) * | 2025-03-12 | 2025-11-04 | 上海百英生物科技股份有限公司 | 一种抗人ccr8单克隆抗体及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007044756A2 (en) * | 2005-10-11 | 2007-04-19 | Icos Corporation | Monoclonal antibodies recognizing human ccr8 |
| BR112021011431A2 (pt) * | 2018-12-27 | 2021-11-23 | Univ Osaka | Anticorpo monoclonal ou um fragmento de anticorpo do mesmo que se liga ao ccr8, seu uso, bem como composição farmacêutica, polinucleotídeo, vetor de expressão e kit |
| AU2021205877B2 (en) * | 2020-01-06 | 2024-06-20 | Vaccinex, Inc. | Anti-CCR8 antibodies and uses thereof |
| TWI890283B (zh) * | 2020-02-14 | 2025-07-11 | 美商基利科學股份有限公司 | 結合ccr8之抗體及融合蛋白及其用途 |
| TW202216771A (zh) * | 2020-06-26 | 2022-05-01 | 德商拜耳廠股份有限公司 | 用於治療應用之ccr8抗體 |
| JP7610302B2 (ja) * | 2020-08-28 | 2025-01-08 | ハーバー・バイオメド・(シャンハイ)・カンパニー・リミテッド | Ccr8抗体及びその用途 |
-
2022
- 2022-08-19 JP JP2024510434A patent/JP2024531409A/ja active Pending
- 2022-08-19 US US18/685,068 patent/US20250019451A1/en active Pending
- 2022-08-19 WO PCT/CN2022/113739 patent/WO2023020621A1/en not_active Ceased
- 2022-08-19 AU AU2022331786A patent/AU2022331786A1/en active Pending
- 2022-08-19 MX MX2024002238A patent/MX2024002238A/es unknown
- 2022-08-19 KR KR1020247007534A patent/KR20240046533A/ko active Pending
- 2022-08-19 EP EP22857930.6A patent/EP4388009A4/en active Pending
- 2022-08-19 CA CA3225986A patent/CA3225986A1/en active Pending
- 2022-08-19 CN CN202280069781.2A patent/CN118176210A/zh active Pending
- 2022-08-19 IL IL310938A patent/IL310938A/en unknown